BHC
Bausch Health Companies Inc.
$4.90
+0.13 (+2.73%)
At close · Jul 2
Market Cap
$1.83B
Shares
373,475,644
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.90
Open$4.85
Day$4.74–4.94
52W$4.57–8.69
Avg vol 30d2.6M
Short int7.4M · 2.0% float · 3.4d
Short vol42%
Last earningsApr 29, 2026
DataJan 2020–Jul 2026
Filing10-Q · Apr 30
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−18% below
−
Price vs 50-day avg
−7% below
◦
RSI (14)
46 · neutral
+
MACD trend
positive
−
52-week position
8% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $5 › 200d $6 — 200d above 50d
−
Institutional flow
-3% holders QoQ · +31 funds added
−
Insider flow
Net -$132.8K over 90 days · 100% sells
−
Short interest
1.99% of float · ▲ +21.5% MoM · 3.4 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
231 holders — mid 3-yr range
Fundamentals
Fair
−
Revenue growth
−10% Y/Y
+
EPS growth
+423% Y/Y
+
Free cash flow
$1.0B
−
Balance sheet
net debt $19.5B
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Jul 29, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−18% below
Bearish
Price vs 50-day avg
−7% below
Bearish
RSI (14)
46 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
8% · near low
Bearish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +31 funds added
Insider flow
Distributing
Net -$132.8K over 90 days · 100% sells
Short interest
Rising
1.99% of float · ▲ +21.5% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
231 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $5
Now $5 · 8%
52-wk high $9
vs 200-day avg -18%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Cash Flow from Operations (non-GAAP) non-GAAP | $1.2B | Full-Year 2025 | — |
| Consolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP) non-GAAP | $3.54B | Full-Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BHC
this stock
Bausch Health Companies Inc.
|
$1.83B | -29.5% | -9.8% | — | 2.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BHC | -7.2% | -1.0% | -36.9% | -0.6% | -29.5% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -8.6% | +0.2% | -45.0% | -0.3% | -38.7% |